Citigroup’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-23,000
Closed -$4.14M 5819
2023
Q4
$4.14M Buy
+23,000
New +$3.58M ﹤0.01% 1717

Other funds holding RGEN

Citigroup's RGEN Position: Q2 2026 in Review

Citigroup reduced its Repligen (RGEN) stake by 46% in Q2 2026, selling an estimated $2.08M and leaving 19,461 shares worth $2.66M. The position accounts for ﹤0.01% of the portfolio, ranked #2714.

Citigroup first reported a position in RGEN in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.9M in Q3 2024. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Citigroup held 19,461 shares of Repligen worth $2.66M as of Q2 2026.
  • Citigroup sold 16,895 Repligen shares in Q2 2026, an estimated $2.08M.
  • Repligen made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2714 holding.
  • Citigroup first reported a position in Repligen in Q2 2013 and has held it in 53 quarters since.
  • Citigroup's Repligen position peaked at $13.9M in Q3 2024.
  • 481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.